C. Brink

1.3k total citations
44 papers, 976 citations indexed

About

C. Brink is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Social Psychology. According to data from OpenAlex, C. Brink has authored 44 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 11 papers in Social Psychology. Recurrent topics in C. Brink's work include Stress Responses and Cortisol (10 papers), Neuroendocrine regulation and behavior (10 papers) and Tryptophan and brain disorders (8 papers). C. Brink is often cited by papers focused on Stress Responses and Cortisol (10 papers), Neuroendocrine regulation and behavior (10 papers) and Tryptophan and brain disorders (8 papers). C. Brink collaborates with scholars based in South Africa, Denmark and Australia. C. Brink's co-authors include Brian H. Harvey, Linda Brand, Francois P. Viljoen, Nico Liebenberg, Carlos Labat, Gregers Wegener, Xavier Norel, Douglas W. Oliver, Bernadette Raffestin and Jacques Cerrina and has published in prestigious journals such as The Astrophysical Journal, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

C. Brink

44 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Brink South Africa	17	280	210	204	142	138	44	976
Jean‐Jacques Benoliel France	16	341 1.2×	366 1.7×	367 1.8×	165 1.2×	106 0.8×	29	1.6k
Philippe Nuss France	16	377 1.3×	138 0.7×	190 0.9×	127 0.9×	80 0.6×	62	1.4k
Romain Colle France	19	240 0.9×	156 0.7×	188 0.9×	336 2.4×	238 1.7×	84	1.2k
Ruth Kohen United States	22	560 2.0×	205 1.0×	687 3.4×	81 0.6×	124 0.9×	40	1.6k
Radhakrishnan Mahesh India	22	395 1.4×	130 0.6×	359 1.8×	282 2.0×	198 1.4×	72	1.3k
Chieh‐Liang Huang Taiwan	15	216 0.8×	168 0.8×	163 0.8×	215 1.5×	94 0.7×	36	1.2k
G. Evoniuk United States	17	300 1.1×	217 1.0×	239 1.2×	54 0.4×	138 1.0×	37	1.0k
Belinda Davis United States	16	261 0.9×	223 1.1×	122 0.6×	216 1.5×	325 2.4×	31	1.5k
Peter M. Liebmann Austria	18	223 0.8×	252 1.2×	157 0.8×	88 0.6×	47 0.3×	38	1.5k
V. Srinivasan United States	16	244 0.9×	336 1.6×	175 0.9×	141 1.0×	72 0.5×	38	1.8k

Countries citing papers authored by C. Brink

Since Specialization

Citations

This map shows the geographic impact of C. Brink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Brink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Brink more than expected).

Fields of papers citing papers by C. Brink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Brink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Brink. The network helps show where C. Brink may publish in the future.

Co-authorship network of co-authors of C. Brink

This figure shows the co-authorship network connecting the top 25 collaborators of C. Brink. A scholar is included among the top collaborators of C. Brink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Brink. C. Brink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harvey, Brian H., Stanislav Gobec, Mohammed Shahid, et al.. (2025). A novel butyrylcholinesterase inhibitor induces antidepressant, pro-cognitive, and anti-anhedonic effects in Flinders Sensitive Line rats: The role of the ghrelin-dopamine cascade. Biomedicine & Pharmacotherapy. 187. 118093–118093. 2 indexed citations

Harvey, Brian H., et al.. (2024). Sildenafil, alone and in combination with imipramine or escitalopram, display antidepressant-like effects in an adrenocorticotropic hormone-induced (ACTH) rodent model of treatment-resistant depression. European Journal of Pharmacology. 969. 176434–176434. 4 indexed citations

Brink, C. & David I. Lewis. (2023). The 12 Rs Framework as a Comprehensive, Unifying Construct for Principles Guiding Animal Research Ethics. Animals. 13(7). 1128–1128. 13 indexed citations

Brink, C., et al.. (2021). The long-term bio-behavioural effects of juvenile sildenafil treatment in Sprague-Dawley versus flinders sensitive line rats. Acta Neuropsychiatrica. 33(4). 200–205. 2 indexed citations

Harvey, Brian H., et al.. (2020). Pre‐pubertal, low‐intensity exercise does not require concomitant venlafaxine to induce robust, late‐life antidepressant effects in Flinders sensitive line rats. European Journal of Neuroscience. 52(8). 3979–3994. 7 indexed citations

Harvey, Brian H., et al.. (2018). Immediate and long-term antidepressive-like effects of pre-pubertal escitalopram and omega-3 supplementation combination in young adult stress-sensitive rats. Behavioural Brain Research. 351. 49–62. 11 indexed citations

Harvey, Brian H., et al.. (2017). Long-lasting effects of fluoxetine and/or exercise augmentation on bio-behavioural markers of depression in pre-pubertal stress sensitive rats. Behavioural Brain Research. 323. 86–99. 22 indexed citations

Brand, Linda, et al.. (2016). Long-term effects of pre-pubertal fluoxetine on behaviour and monoaminergic stress response in stress-sensitive rats. Acta Neuropsychiatrica. 29(4). 222–235. 14 indexed citations

Harvey, Brian H., et al.. (2015). Ozone exposure of Flinders Sensitive Line rats is a rodent translational model of neurobiological oxidative stress with relevance for depression and antidepressant response. Psychopharmacology. 232(16). 2921–2938. 55 indexed citations

10.

Harvey, Brian H., et al.. (2015). Prospective analysis of the medicine possession ratio of antidepressants in the private health sector of South Africa, 2006 - 2011. South African Medical Journal. 105(2). 139–139. 4 indexed citations

11.

Liebenberg, Nico, Heidi Kaastrup Müller, Christina Weide Fischer, et al.. (2011). An inhibitor of cAMP-dependent protein kinase induces behavioural and neurological antidepressant-like effects in rats. Neuroscience Letters. 498(2). 158–161. 14 indexed citations

12.

Harvey, Brian H., et al.. (2010). Ozone modulates the effects of imipramine on immobility in the forced swim test, and nonspecific parameters of hippocampal oxidative stress in the rat. Metabolic Brain Disease. 25(2). 125–133. 30 indexed citations

13.

Liebenberg, Nico, Brian H. Harvey, Linda Brand, & C. Brink. (2010). Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression. Behavioural Pharmacology. 21(5-6). 540–547. 50 indexed citations

14.

Harvey, Brian H., Francois P. Viljoen, Sarel F. Malan, et al.. (2010). Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues. Biochemical Pharmacology. 80(10). 1580–1591. 58 indexed citations

15.

Liebenberg, Nico, Gregers Wegener, Brian H. Harvey, & C. Brink. (2010). Investigating the role of protein kinase-G in the antidepressant-like response of sildenafil in combination with muscarinic acetylcholine receptor antagonism. Behavioural Brain Research. 209(1). 137–141. 18 indexed citations

16.

Brink, C., Brian H. Harvey, & Linda Brand. (2006). Tianeptine: A Novel Atypical Antidepressant that May Provide New Insights into the Biomolecular Basis of Depression. PubMed. 1(1). 29–41. 54 indexed citations

17.

Brink, C., et al.. (2005). Phenoxybenzamine and Benextramine, but Not 4-Diphenylacetoxy-N-[2-chloroethyl]piperidine Hydrochloride, Display Irreversible Noncompetitive Antagonism at G Protein-Coupled Receptors. Journal of Pharmacology and Experimental Therapeutics. 314(2). 891–905. 6 indexed citations

18.

Brink, C., et al.. (2004). Effects of myo-Inositol Versus Fluoxetine and Imipramine Pretreatments on Serotonin 5HT2A and Muscarinic Acetylcholine Receptors in Human Neuroblastoma Cells. Metabolic Brain Disease. 19(1-2). 51–70. 12 indexed citations

19.

Harvey, Brian H., C. Brink, Soraya Seedat, & Dan J. Stein. (2002). Defining the neuromolecular action of myo-inositol. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(1). 21–32. 38 indexed citations

20.

Ortiz, J.L., Carlos Labat, Xavier Norel, et al.. (1992). Histamine receptors on human isolated pulmonary arterial muscle preparations: effects of endothelial cell removal and nitric oxide inhibitors.. Journal of Pharmacology and Experimental Therapeutics. 260(2). 762–767. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact